Biocompatibility of phosphorylcholine coated stents in normal porcine coronary arteries

Heart

Volumn 83, Issue 3, 2000, Pages 338-345

  Whelan, D M ^a   Van Der Giessen, W J ^a   Krabbendam, S C ^a   Van Vliet, E A ^a   Verdouw, P D ^a   Serruys, P W ^a   Van Beusekom, H M M ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Biocompatible materials; Coatings; Phosphorylcholine; Stents

Indexed keywords

PHOSPHORYLCHOLINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERY INTIMA PROLIFERATION; ARTICLE; BIOCOMPATIBILITY; CONTROLLED STUDY; CORONARY ARTERY; CORONARY STENT; IMPLANTATION; NONHUMAN; PRIORITY JOURNAL; SWINE; THROMBOSIS;

EID: 0034022046     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/heart.83.3.338     Document Type: Article

References (34)

1. Moussa I, Di Mario C, Di Francesco L, et al. Subacute stent thrombosis and the anticoagulation controversy: changes in drug therapy, operator technique, and the impact of intravascular ultrasound. Am J Cardiol 1996;78(suppl 3A):13-17.
2. Keane D, Haase J, Slager CJ, et al. Comparative validation of quantitative coronary angiography systems. Results and implications from a multicenter study using a standardised approach. Circulation 1995;91:2174-83.
3. Goods CM, Al-Shaibi KF, Yadav SS, et al. Utilisation of the coronary balloon-expandable coil stent without anticoagulation or intravascular ultrasound. Circulation 1996;93:1803-8.
4. von Segesser LK, Olah A, Leskosek B, et al. Coagulation patterns in bovine left heart bypass with phospholipid versus heparin surface coating. ASAIO J 1993;39:43-6.
5. Hunter S, Angelini GD. Phosphatidylcholine-coated chest tubes improve drainage after open heart operation. Ann Thorac Surg 1993;56:1339-42.
6. Veil KR, Chronos NAF, Palmer SJ, et al. Phosphorylcholine: a biocompatible coating for coronary angioplasty devices [abstract]. Circulation 1995;92:2337.
7. Plante S, Juneau C. Thrombogenicity of PTCA guide wires: a scanning electron microscopy study [abstract]. Circulation 1997;96:4243.
8. Campbell EJ, O'Byrne V, Stratford PW, et al. Biocompatible surfaces using methacryloylphosphorylcholine laurylmethacrylate copolymer. ASAIO J 1994,40:M853-7.
9. van der Giessen WJ, Lincoff AM, Schwartz RS, et al. Marked inflammatory sequelae to implantation of biodegradable and nonbiodegradable polymers in porcine coronary arteries. Circulation 1996;94:1690-7.
10. van der Giessen WJ, Serruys PW, van Beusekom HM, et al. Coronary stenting with a new, radiopaque, balloon-expandable endoprosthesis in pigs. Circulation 1991;83:1788-98.
11. Reiber JH, Serruys PW, Kooijman CJ, et al. Assessment of short-, medium-, and long-term variations in arterial dimensions from computer-assisted quantitation of coronary cineangiograms. Circulation 1985;71:280-8.
12. van Beusekom HMM, Whelan DM, Van der Plas M, et al. A practical and rapid method of histological processing for examination of coronary arteries containing metallic stents. Cardiovascular Pathology 1996;5:69-76.
13. van Beusekom HMM, van der Giessen WJ, Wagenvoort CA, et al. Histological features of a polymer endovascular prosthesis after transcatheter implantation in porcine arteries. Cardiovascular Pathology 1993;2:41-51.
14. Baron JH, de Bono DP, Azrin MA, et al. Adsorption and elution of c7E3Fab from polymer-coated stents in vitro: local delivery of an anti-thrombotic agent that also may inhibit restenosis [abstract]. Circulation 1997;96:2254.
15. McKenna CJ, Camrud AR, Wolff R, et al. Fibrin-film stenting in a porcine coronary injury model: efficacy and safety compared to uncoated stents [abstract]. Circulation 1997;96:81.
16. Chen C, Lumsden AB, Ofenloch JC, et al. Phosphorylcholine coating of ePTFE grafts reduces neointimal hyperplasia in canine model. Ann Vasc Surg 1997;11:74-9.
17. Hardhammar PA, van Beusekom HMM, Emanuelsson HU, et al. Reduction in thrombotic events with heparin-coated Palmaz-Schatz stents in normal porcine coronary arteries. Circulation 1996;93:423-30.
18. Rogers C, Edelman ER. Endovascular stent design dictates experimental restenosís and thrombosis. Circulation 1995;91:2995-3001.
19. Ikada Y. Surface modification of polymers for medical applications. Biomaterials 1994;15:725-36.
20. van Wachem PB, Vreriks CM, Beugeling T, et al. The influence of protein adsorption on interactions of cultured human endothelial cells with polymers. J Biomed Mater Res 1987;21:701-18.
21. Kuiper KKJ, Robinson KA, Chronos NAF, et al. Phosphorylcholine-coated metallic stents in rabbit iliac and porcine coronary arteries. Scand Cardiovasc J 1998;32:261-8.
22. Tolhurst LA. The analysis of post implant biodivYsio stents. Proceedings of the Medical Device Technology Conference, March 1999, London, UK. Chester, UK: Advanstar Communications, 1999:427-41.
23. Lincoff AM, Furst JG, Ellis SG, et al. Sustained local delivery of dexamethasone by a novel intravascular eluting stent to prevent restenosis in the porcine coronary injury model. J Am Coll Cardiol 1997;29:808-16.
24. Wilczek K, Scheerder ID, Wang K, et al. Comparison of self-expanding polyethylene terephthalate and metallic stents implanted in porcine iliac arteries. Cardiovasc Intervent Radiol 1996;19:176-80.
25. Murphy JG, Schwartz RS, Edwards WD, et al. Percutaneous polymeric stents in porcine coronary arteries. Initial experience with polyethylene terephthalate stents. Circulation 1992;86:1596-604.
26. van der Giessen WJ, van Beusekom HMM, van Houten CD, et al. Coronary stenting with polymer-coated and uncoated self-expanding endoprostheses in pigs. Coronary Artery Disease 1992;3:631-40.
27. de Scheerder I, Wang K, Wilczek K, et al. Local methylprednisolone inhibition of foreign body response to coated intracoronary stents. Coronary Artery Disease 1996;7:161-6.
28. Cox DA, Anderson PG, Roubin GS, et al. Effect of local delivery of heparin and methotrexate on neointimal proliferation in stented porcine coronary arteries. Coronary Artery Disease 1992;3:238-48.
29. De Scheerder IK, Wilczek KL, Verbeken EV, et al. Biocompatibility of polymer-coated oversized metallic stents implanted in normal porcine coronary arteries. Atherosclerosis 1995;114:105-14.
30. De Scheerder IK, Wilczek KL, Verbeken EV, et al. Biocompatibility of biodegradable and nonbiodegradable polymer-coated stents implanted in porcine peripheral arteries. Cardiovasc Intervent Radiol 1995;18:227-32.
31. Fontaine AB, Koelling K, Passos SD, et al. Polymeric surface modifications of tantalum stents. J Endovasc Surg 1996;3:276-83.
32. Dev V, Eigler N, Sheth S, et al. Kinetics of drug delivery to the arterial wall via polyurethane-coated removable nitinol stent: comparative study of two drugs. Cathet Cardiovasc Diagn 1995;34:272-8.
33. Lambert TL, Dev V, Rechavia E, et al. Localised arterial wall drug delivery from a polymer-coated removable metallic stent. Kinetics, distribution, and bioactivity of forskolin. Circulation 1994,90:1003-11.
34. Aggarwal RK, Ireland DC, Azrin MA, et al. Antithrombotic potential of polymer-coated stents eluting platelet glyco-protein IIb/IIIa receptor antibody. Circulation 1996;94:3311-17.